Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 25 |
| List of Tables | 22 | 4 |
| List of Figures | 26 | 1 |
| Introduction | 27 | 1 |
| Global Markets Direct Report Coverage | 27 | 1 |
| Depression Overview | 28 | 1 |
| Therapeutics Development | 29 | 2 |
| Pipeline Products for Depression Overview | 29 | 1 |
| Pipeline Products for Depression Comparative Analysis | 30 | 1 |
| Depression Therapeutics under Development by Companies | 31 | 8 |
| Depression Therapeutics under Investigation by Universities/Institutes | 39 | 2 |
| Depression Pipeline Products Glance | 41 | 4 |
| Late Stage Products | 41 | 1 |
| Clinical Stage Products | 42 | 1 |
| Early Stage Products | 43 | 1 |
| Unknown Stage Products | 44 | 1 |
| Depression Products under Development by Companies | 45 | 11 |
| Depression Products under Investigation by Universities/Institutes | 56 | 2 |
| Depression Companies Involved in Therapeutics Development | 58 | 92 |
| AB Science SA | 58 | 1 |
| Acetylon Pharmaceuticals, Inc. | 59 | 1 |
| Ache Laboratorios Farmaceuticos S/A | 60 | 1 |
| Adamed Sp. z o.o. | 61 | 1 |
| Addex Therapeutics Ltd | 62 | 1 |
| Aequus Pharmaceuticals Inc. | 63 | 1 |
| Alkermes Plc | 64 | 1 |
| Allergan Plc | 65 | 1 |
| Alvogen Korea Co., Ltd. | 66 | 1 |
| Amorsa Therapeutics Inc. | 67 | 1 |
| Anavex Life Sciences Corp. | 68 | 1 |
| Angelini Group | 69 | 1 |
| Angita B.V. | 70 | 1 |
| Araim Pharmaceuticals, Inc. | 71 | 1 |
| AstraZeneca Plc | 72 | 1 |
| Avanir Pharmaceuticals, Inc. | 73 | 1 |
| Axsome Therapeutics Inc | 74 | 1 |
| Azevan Pharmaceuticals, Inc. | 75 | 1 |
| BioCrea GmbH | 76 | 1 |
| Biogen Inc | 77 | 1 |
| Biohaven Pharmaceutical Holding Company Limited | 78 | 1 |
| BioLite, Inc. | 79 | 1 |
| Bionomics Limited | 80 | 1 |
| Boehringer Ingelheim GmbH | 81 | 1 |
| Bristol-Myers Squibb Company | 82 | 1 |
| Calico LLC | 83 | 1 |
| Celon Pharma Sp. z o.o. | 84 | 1 |
| Cerecor Inc. | 85 | 1 |
| Clera Inc. | 86 | 1 |
| D-Pharm Ltd. | 87 | 1 |
| Delpor, Inc. | 88 | 1 |
| e-Therapeutics Plc | 89 | 1 |
| Eisai Co., Ltd. | 90 | 1 |
| Eli Lilly and Company | 91 | 1 |
| Evotec AG | 92 | 1 |
| Fabre-Kramer Pharmaceuticals, Inc. | 93 | 1 |
| GlaxoSmithKline Plc | 94 | 1 |
| GliaCure Inc. | 95 | 1 |
| H. Lundbeck A/S | 96 | 1 |
| Heptares Therapeutics Limited | 97 | 1 |
| Hua Medicine (Shanghai) Ltd. | 98 | 1 |
| Hyundai Pharmaceutical Co., Ltd. | 99 | 1 |
| Impel NeuroPharma, Inc. | 100 | 1 |
| INSYS Therapeutics, Inc. | 101 | 1 |
| Intas Pharmaceuticals Ltd. | 102 | 1 |
| Intra-Cellular Therapies, Inc. | 103 | 1 |
| INVENT Pharmaceuticals, Inc. | 104 | 1 |
| Johnson &Johnson | 105 | 1 |
| KemPharm, Inc. | 106 | 1 |
| Lead Discovery Center GmbH | 107 | 1 |
| Les Laboratoires Servier SAS | 108 | 1 |
| Lixte Biotechnology Holdings, Inc. | 109 | 1 |
| Luye Pharma Group Ltd. | 110 | 1 |
| Mapi Pharma Ltd. | 111 | 1 |
| Mapreg S.A.S. | 112 | 1 |
| Meta-IQ ApS | 113 | 1 |
| Methylation Sciences Inc. | 114 | 1 |
| miCure Therapeutics Ltd. | 115 | 1 |
| Mitsubishi Tanabe Pharma Corporation | 116 | 1 |
| Navya Biologicals Pvt Ltd | 117 | 1 |
| Neuralstem, Inc. | 118 | 1 |
| Neurocrine Biosciences, Inc. | 119 | 1 |
| NeuroNascent, Inc. | 120 | 1 |
| NeurOp, Inc | 121 | 1 |
| Newron Pharmaceuticals S.p.A. | 122 | 1 |
| Nippon Chemiphar Co., Ltd. | 123 | 1 |
| nLife Therapeutics, S.L. | 124 | 1 |
| Novartis AG | 125 | 1 |
| Omeros Corporation | 126 | 1 |
| Otsuka Holdings Co., Ltd. | 127 | 1 |
| Pfizer Inc. | 128 | 1 |
| Pherin Pharmaceuticals, Inc. | 129 | 1 |
| Polleo Pharma Limited | 130 | 1 |
| Protagenic Therapeutics Inc. | 131 | 1 |
| Relmada Therapeutics, Inc. | 132 | 1 |
| Reviva Pharmaceuticals Inc. | 133 | 1 |
| Richter Gedeon Nyrt. | 134 | 1 |
| Saniona AB | 135 | 1 |
| SK Biopharmaceuticals Co., Ltd. | 136 | 1 |
| Sumitomo Dainippon Pharma Co., Ltd. | 137 | 1 |
| Supernus Pharmaceuticals, Inc. | 138 | 1 |
| Suven Life Sciences Ltd. | 139 | 1 |
| Taisho Pharmaceutical Holdings Co., Ltd. | 140 | 1 |
| Takeda Pharmaceutical Company Limited | 141 | 1 |
| Tetra Discovery Partners LLC | 142 | 1 |
| Trevena, Inc. | 143 | 1 |
| TRImaran Pharma, Inc. | 144 | 1 |
| Turing Pharmaceuticals AG | 145 | 1 |
| VistaGen Therapeutics , Inc. | 146 | 1 |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 147 | 1 |
| Zogenix, Inc. | 148 | 1 |
| Zysis Limited | 149 | 1 |
| Depression Therapeutics Assessment | 150 | 20 |
| Assessment by Monotherapy Products | 150 | 1 |
| Assessment by Combination Products | 151 | 1 |
| Assessment by Target | 152 | 7 |
| Assessment by Mechanism of Action | 159 | 7 |
| Assessment by Route of Administration | 166 | 2 |
| Assessment by Molecule Type | 168 | 2 |
| Drug Profiles | 170 | 281 |
| (aripiprazole + sertraline hydrochloride) Drug Profile | 170 | 1 |
| (buprenorphine hydrochloride + samidorphan l-malate) Drug Profile | 171 | 5 |
| (bupropion hydrochloride + dextromethorphan hydrobromide) Drug Profile | 176 | 2 |
| (cycloserine + lurasidone hydrochloride) Drug Profile | 178 | 1 |
| (dextromethorphan + quinidine sulfate) Drug Profile | 179 | 5 |
| AAD-2004 Drug Profile | 184 | 1 |
| ACY-738 Drug Profile | 185 | 1 |
| ACY-775 Drug Profile | 186 | 1 |
| ADN-2013 Drug Profile | 187 | 1 |
| ADX-88178 Drug Profile | 188 | 2 |
| ALKS-7119 Drug Profile | 190 | 1 |
| Alstriol Drug Profile | 191 | 1 |
| AMR-2 Drug Profile | 192 | 1 |
| AMS-410 FA Drug Profile | 193 | 1 |
| AMS-520 Drug Profile | 194 | 1 |
| AN-788 Drug Profile | 195 | 1 |
| ANAVEX-141 Drug Profile | 196 | 1 |
| ANAVEX-273 Drug Profile | 197 | 8 |
| apimostinel Drug Profile | 205 | 2 |
| aripiprazole Drug Profile | 207 | 2 |
| aripiprazole CR Drug Profile | 209 | 1 |
| aripiprazole ER Drug Profile | 210 | 1 |
| AV-101 Drug Profile | 211 | 3 |
| AVN-628 Drug Profile | 214 | 1 |
| AVP-786 Drug Profile | 215 | 3 |
| BLI-1005 Drug Profile | 218 | 1 |
| BNC-210 Drug Profile | 219 | 3 |
| brexpiprazole Drug Profile | 222 | 5 |
| bupropion hydrochloride ER Drug Profile | 227 | 1 |
| cariprazine Drug Profile | 228 | 6 |
| CB-1407 Drug Profile | 234 | 1 |
| CB-2202 Drug Profile | 235 | 1 |
| CB-2803 Drug Profile | 236 | 1 |
| CCG-63802 Drug Profile | 237 | 1 |
| CERC-301 Drug Profile | 238 | 2 |
| CERC-501 Drug Profile | 240 | 2 |
| cibinetide Drug Profile | 242 | 3 |
| CLR-3001 Drug Profile | 245 | 1 |
| CNV-1061436 Drug Profile | 246 | 1 |
| CX-157 Drug Profile | 247 | 2 |
| D-473 Drug Profile | 249 | 1 |
| dehydroevodiamine hydrochloride Drug Profile | 250 | 1 |
| DG-071 Drug Profile | 251 | 1 |
| DP-VPA Drug Profile | 252 | 2 |
| DSP-1200 Drug Profile | 254 | 1 |
| DSR-98776 Drug Profile | 255 | 1 |
| E-2508 Drug Profile | 256 | 1 |
| ebselen Drug Profile | 257 | 1 |
| Endoxifen Drug Profile | 258 | 2 |
| esketamine hydrochloride Drug Profile | 260 | 3 |
| esketamine hydrochloride Drug Profile | 263 | 1 |
| etomoxir Drug Profile | 264 | 1 |
| evenamide Drug Profile | 265 | 3 |
| EVT-100 Series Drug Profile | 268 | 1 |
| EVT-103 Drug Profile | 269 | 2 |
| FKB-01MD Drug Profile | 271 | 1 |
| gepirone hydrochloride ER Drug Profile | 272 | 1 |
| HOB-075 Drug Profile | 273 | 1 |
| HTL-14242 Drug Profile | 274 | 1 |
| HUF-101 Drug Profile | 275 | 1 |
| hydroxynorketamine Drug Profile | 276 | 1 |
| I-105 Drug Profile | 277 | 1 |
| INV-107 Drug Profile | 278 | 1 |
| INV-331 Drug Profile | 279 | 1 |
| ITI-007 Drug Profile | 280 | 8 |
| JDTic Drug Profile | 288 | 1 |
| JNJ-18038683 Drug Profile | 289 | 1 |
| JNJ-31020028 Drug Profile | 290 | 1 |
| JNJ-42847922 Drug Profile | 291 | 4 |
| JNJ-47965567 Drug Profile | 295 | 1 |
| JRP-227 Drug Profile | 296 | 1 |
| JRP-362 Drug Profile | 297 | 1 |
| ketamine hydrochloride Drug Profile | 298 | 1 |
| KP-303 Drug Profile | 299 | 1 |
| KW-21072 Drug Profile | 300 | 1 |
| LB-100 Drug Profile | 301 | 2 |
| LPM-570065 Drug Profile | 303 | 1 |
| lurasidone hydrochloride Drug Profile | 304 | 8 |
| LY-03005 Drug Profile | 312 | 1 |
| LY-2607540 Drug Profile | 313 | 1 |
| LY-341495 Drug Profile | 314 | 1 |
| MAP-4343 Drug Profile | 315 | 1 |
| masitinib Drug Profile | 316 | 12 |
| MIN-117 Drug Profile | 328 | 2 |
| miR-135 Drug Profile | 330 | 1 |
| MSI-195 Drug Profile | 331 | 1 |
| naloxone hydrochloride Drug Profile | 332 | 1 |
| NAV-003 Drug Profile | 333 | 1 |
| NC-2800 Drug Profile | 334 | 1 |
| NLF-NEU Drug Profile | 335 | 1 |
| NNI-351 Drug Profile | 336 | 1 |
| NP-11948 Drug Profile | 337 | 1 |
| NSI-189 Drug Profile | 338 | 4 |
| onabotulinumtoxin A Drug Profile | 342 | 5 |
| OPC-64005 Drug Profile | 347 | 1 |
| P7-C3A20 Drug Profile | 348 | 1 |
| paliperidone palmitate Drug Profile | 349 | 1 |
| PDI-42 Drug Profile | 350 | 1 |
| PGW-5 Drug Profile | 351 | 1 |
| PH-10 Drug Profile | 352 | 1 |
| PN-6047 Drug Profile | 353 | 1 |
| PP-001 Drug Profile | 354 | 1 |
| PQ-001 Drug Profile | 355 | 1 |
| PT-00114 Drug Profile | 356 | 1 |
| quetiapine fumarate ER Drug Profile | 357 | 1 |
| rapastinel Drug Profile | 358 | 4 |
| REL-1017 Drug Profile | 362 | 3 |
| riluzole Drug Profile | 365 | 3 |
| risperidone Drug Profile | 368 | 2 |
| risperidone Drug Profile | 370 | 1 |
| risperidone Drug Profile | 371 | 1 |
| RO-05 Drug Profile | 372 | 1 |
| RP-5063 Drug Profile | 373 | 2 |
| S-47445 Drug Profile | 375 | 1 |
| sirukumab Drug Profile | 376 | 4 |
| SKL-PSY Drug Profile | 380 | 1 |
| Small Molecule 1 to Inhibit Dopamine Transporter, Noradrenaline Transporter and Serotonin Transporter for Depression Drug Profile | 381 | 1 |
| Small Molecule for Bipolar Disorder Drug Profile | 382 | 1 |
| Small Molecule for Cancer and Neurodegenerative Disease Drug Profile | 383 | 1 |
| Small Molecule for Depression Drug Profile | 384 | 1 |
| Small Molecule for Insomnia, Obesity and Treatment Resistant Depression Drug Profile | 385 | 1 |
| Small Molecule to Activate Kappa Opioid Receptor for CNS Drug Profile | 386 | 1 |
| Small Molecule to Activate LPL for CNS and Metabolic Disorders Drug Profile | 387 | 1 |
| Small Molecule to Activate TrkB Receptor for Central Nervous System, Metabolic Disorders and ENT Disorders Drug Profile | 388 | 1 |
| Small Molecule to Agonize Adenosine Receptor A1 for Depression Drug Profile | 389 | 1 |
| Small Molecule to Agonize CB1 Receptor for Inflammatory and Neuropathic Pain Drug Profile | 390 | 1 |
| Small Molecule to Agonize Opioid Delta for Depression Drug Profile | 391 | 1 |
| Small Molecule to Antagonize GPR78 for Bipolar Disorder and Schizophrenia Drug Profile | 392 | 1 |
| Small Molecule to Antagonize NK1R and Block SERT for Depression Drug Profile | 393 | 1 |
| Small Molecule to Antagonize Vasopressin V1b Receptor for Depression Drug Profile | 394 | 1 |
| Small Molecule to Block TREK for Depression Drug Profile | 395 | 1 |